New lens offers hope for clearer vision in cataract patients with keratoconus
NCT ID NCT07338708
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special intraocular lens (Vivity EDOF) in 10 adults who had cataracts and mild keratoconus, a condition that thins and bulges the cornea. All participants received the lens in both eyes during standard cataract surgery. The goal was to see if the lens could provide good distance, intermediate, and near vision while maintaining safety and quality of life. Participants were followed for 3 months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Extended Depth of Focus Intraocular Lens (AcrySof IQ Vivity)
What this could lead to
If successful, this lens could offer a safe option for people with both cataracts and mild keratoconus to see clearly at multiple distances without glasses.
What could go wrong
This was a very small study (10 people) with no comparison group, so results may not apply to everyone. Mild keratoconus can progress, and the lens may not work as well in more advanced cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliera Integrata di Verona
Verona, Verona, 37134, Italy